CL vs EBS
Colgate-Palmolive Company (CL) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
CL currently screens at market cap $70.88B and trailing P/E 34.3. EBS currently screens at market cap $416.4M.
Not investment advice. Open the CL and EBS stock pages for the full models.
Not investment advice.